Detection of human T-cell lymphotropic virus type I-specific cytotoxic T-cells may predict treatment responses in adult T-cell leukemia/lymphoma patients

Ann Hematol. 2017 Sep;96(9):1587-1588. doi: 10.1007/s00277-017-3052-4. Epub 2017 Jun 27.

Authors

Hiroshi Ureshino^{1

2}, Kazuharu Kamachi³, Masaharu Miyahara³

Affiliations

¹ Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan. [email protected].
² Department of Internal Medicine, Karatsu Red Cross Hospital, Karatsu, Japan. [email protected].
³ Department of Internal Medicine, Karatsu Red Cross Hospital, Karatsu, Japan.

PMID: 28656327
DOI: 10.1007/s00277-017-3052-4

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged, 80 and over
Antibodies, Monoclonal, Humanized / therapeutic use
Antineoplastic Agents, Immunological / therapeutic use
Antineoplastic Agents, Phytogenic / therapeutic use
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Cyclophosphamide / administration & dosage
Doxorubicin / administration & dosage
Etoposide / therapeutic use
Female
Human T-lymphotropic virus 1 / immunology*
Humans
Leukemia-Lymphoma, Adult T-Cell / drug therapy
Leukemia-Lymphoma, Adult T-Cell / immunology*
Prednisolone / administration & dosage
Prognosis
T-Cell Antigen Receptor Specificity*
T-Lymphocytes, Cytotoxic / immunology*
Vincristine / administration & dosage

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
Antineoplastic Agents, Phytogenic
Vincristine
Etoposide
Doxorubicin
Cyclophosphamide
Prednisolone
mogamulizumab

Supplementary concepts

VAP-cyclo protocol